Banner webinar 29 april 2020

Rapid Narcotics Analysis by Orthogonal Methods: MS meets NMR

Detection of illegal drugs is an ongoing battle and the rapid analysis and identification of prohibited substances is critical to prevent their importation and widespread distribution.
This webinar took place on April 29th 2020

Register to download slides & media

Overview

Detection of illegal drugs is an ongoing battle and the rapid analysis and identification of prohibited substances is critical to prevent their importation and widespread distribution. Additionally, the data generated needs to be significantly robust for submission in court cases. In most countries across the globe, a minimum of two orthogonal analytical methods must be used in drug testing to provide detailed and admissible evidence. Nuclear Magnetic Resonance and Mass Spectrometry are well established key methods for narcotics analysis, and operate on fundamentally different scientific principles, thus providing definitive identifications. Both methods validate each other and are now brought to your lab bench by Bruker. Today, Bruker’s powerful approach provides enhanced ease of use and maximized method compliance. Bruker supports leading law enforcement authorities worldwide. Become part of the community!

Key learning objectives

  • Increase evidence robustness by application of orthogonal methods
  • Take advantage of training and maintenance synergies from one single point of contact
  • Enhance ease of use and through put with harmonized methods
  • Shorten time to result with benchtop instruments in every local laboratory

Who should attend?

This webinar will be of interest to those working in forensic laboratories, law enforcement authorities, customs & border protection agencies, regulatory bodies, official control laboratories and undertaking analysis of narcotics or suspected narcotics.

Speakers

Dr. Venita Decker
Dr. Venita Decker
Product Manager FT-NMR benchtop solutions, BBIO, Bruker BioSpin, Rheinstetten, Germany
Dr. Venita Decker studied Neuroscience, but did her dissertation in the field of solid-state NMR (Max Planck Institute for Biophysical Chemistry, Goettingen). In 2012, she joined the Bruker solid-state NMR application. As a NMR-late entrant she since then actively supported Bruker solutions that simplify the complexity of NMR (TopSolids, the minispec FormCheck). Since 2018, she is the Product Manager for FT-NMR benchtop solutions, bringing her mission to the next level.
Dr. Joerg Koehler
Dr. Joerg Koehler
Head of Business Unit Industrial, Bruker BioSpin, Rheinstetten, Germany
Dr. Joerg Koehler studied physics and holds a doctoral degree from the Institute of Biophysics and Physical Biochemistry of the University of Regensburg. His research focused on High-Pressure-NMR based studies of folding intermediates of biochemically active macromolecules. After several positions in sales, sales management and business administration he joined Bruker as Head of Business Unit Industrial. Today Dr Joerg Koehler is accountable for Bruker’s global activities in magnetic resonance in various industrial market segments including forensics.
Dr. Andrea Kiehne
Dr. Andrea Kiehne
Head of Bremen applied solutions demo team, Bruker Daltonik, Bremen
Dr. Andrea Kiehne is a highly experienced mass spectrometrist with over 20 years’ experience of applying nominal mass, accurate mass and trapped ion mobility MS systems to the analysis of complex matrices including forensic samples. She joined Bruker in 1998 having completed her PhD in Food Chemistry at the University of Braunschweig, Germany followed by a Post-Doctoral position also at the University of Braunschweig. Currently she is Head of Bruker’s applied solutions demo team at our Bremen facility.